A new tread in interventional cardiology - drug-containing stents

A new tread in interventional cardiology - drug-containing stents

Bibliographic Details
Main Authors:	N Kipshidze, J Moses, R V Sirraius, A Kolomho, N N Kipshidze, M B Leon
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2003-09-01
Series:	Терапевтический архив
Subjects:	coronary angioplasty coronary stents restenosis prophylaxis medicinal stents rapamycin maxol
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29673

Similar Items

Лечение коронарного атеросклероза: влияние массового применения стентов на ближайшие и отдаленные результаты коронарной ангиопластики
by: А. М. Бабунашвили, et al.
Published: (2011-02-01)

Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
by: MohammadSadegh Parsaee, et al.
Published: (2015-10-01)

Implante de stent eluído com batimastat para o tratamento da doença arterial coronariana: resultados do estudo piloto brasileiro Batimastat-eluting stent implantation for the treatment of coronary artery disease: results of the Brazilian pilot study
by: Cristiana Marques de Araujo, et al.
Published: (2005-03-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

A comparative analysis of primary stenting and optimal balloon coronary angioplasty in acute myocardial infarction. Six month results from the STENT PAMI trial
by: Luiz Alberto Mattos, et al.
Published: (2000-12-01)

PERCUTANEOUS CORONARY INTERVENTIONS – CURRENT STATE OF DEVELOPMENT: STENTS EVOLUTION
by: Chernyak A. A., et al.
Published: (2020-11-01)

Safety and efficacy of coronary stent implantation. Acute and six month outcomes of 1,126 consecutive patients treated in 1996 and 1997
by: Luiz Alberto Mattos, et al.
Published: (1999-07-01)

Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure
by: Tommaso Gori
Published: (2021-01-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)
by: Tommaso Gori
Published: (2022-06-01)

Risk factors,pathogenic mechanisms and treatment progress of coronary in-stent restenosis
by: Zha Lingfeng, et al.
Published: (2024-09-01)

Longitudinal Stent Elongation: A Rare Complication of Third-Generation Drug-eluting Stent Platform
by: Dibya Kumar Baruah, et al.
Published: (2024-04-01)

Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease
by: Luciano Maurício de Abreu Filho, et al.
Published: (2011-01-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Electrospun bioresorbable polymer membranes for coronary artery stents
by: Maria A. Rezvova, et al.
Published: (2024-08-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
by: Ganesh Paramasivam, et al.
Published: (2019-11-01)

Evolução clínica pós-stent coronariano em pacientes submetidos a transplante de rim Clinical outcome of renal transplant patients after coronary stenting
by: Fábio Monteiro Mota, et al.
Published: (2007-05-01)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

Stent-grafts versus drug-eluting stents in arterial aneurysms, insights from the International Coronary Artery Aneurysm Registry (CAAR)
by: Iván J. Núñez-Gil, et al.
Published: (2022-05-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

Endovascular treatment of symptomatic severe intracranial atherosclerotic stenosis with a novel intracranial dedicated drug-eluting stent: a more effective treatment approach
by: Lin Ma, et al.
Published: (2024-02-01)

Factors Associated with Development of in Coronary Stent Restenosis — the Results of a Multislice Computed Tomography 1-year Follow-up Study
by: Jani Laura, et al.
Published: (2016-06-01)

The Proliferation REduction with Vascular ENergy Trial (PREVENT)
by: Kaluza Grzegorz L, et al.
Published: (2001-02-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Prediction of Coronary Artery Restenosis in Patients Undergoing Angioplasty
by: F Ebrahimzadeh, et al.
Published: (2018-05-01)

Hybrid revascularization: stenting of left internal carotid artery after restenosis, combined with left anterior descending artery stenting and right carotid endarterectomy
by: Anton N. Kazantsev, et al.
Published: (2022-06-01)

Longitudinal Stent Deformation in Undeployed Stents: A Case Series
by: Parminder Singh Otaal, et al.
Published: (2021-07-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

Mechanism of Drug-Eluting Stent Thrombosis Diagnosed by Histopathological Evaluation of Directional Coronary Atherectomy Specimen
by: Kazuki Ito, MD, et al.
Published: (2023-12-01)

Risk factors of in-stent restenosis after carotid angioplasty and stenting: long-term follow-up study
by: Sangil Park, et al.
Published: (2024-08-01)

The problem ofpreventing vascular restenosis after implantation of a coronary stent
by: А В Sumarokov, et al.
Published: (2004-08-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Restenosis risk factors after coronary stenting in metabolic syndrome patients
by: N. M. Danilov, et al.
Published: (2007-04-01)

Genetic predisposition for the development of complications in patients after coronary artery stenting
by: Dana Taizhanova, et al.
Published: (2019-12-01)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
by: Anis Ghariani, et al.
Published: (2022-05-01)

Structural and Hemodynamic Analyses of Different Stent Structures in Curved and Stenotic Coronary Artery
by: Lingling Wei, et al.
Published: (2019-12-01)

Percutaneous handling of coronary lesions >20mm through stents. Is there a first choice strategy?
by: Luiz Fernando L. Tanajura, et al.
Published: (1999-10-01)

Safety and efficacy of angioplasty with intracoronary stenting in patients with unstable coronary syndromes. Comparison with stable coronary syndromes
by: Luís C. L. Correia, et al.
Published: (2000-06-01)